Kyntra Bio, Inc. (KYNB)
7.39
+0.31
(+4.38%)
USD |
NASDAQ |
Apr 14, 16:00
7.39
0.00 (0.00%)
After-Hours: 19:47
Kyntra Bio Market Cap : 29.87M for April 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anixa Biosciences, Inc. | 96.23M |
| GT Biopharma, Inc. | 12.14M |
| Gossamer Bio, Inc. | 100.36M |
| Monte Rosa Therapeutics, Inc. | 1.401B |
| Septerna, Inc. | 1.081B |
Market Cap Related Metrics
| PE Ratio | 0.2363 |
| PS Ratio | 32.44 |
| Price | 7.39 |
| Earnings Yield | 423.1% |
| Normalized PE Ratio | 0.2275 |